Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition

Cédric Leroy(Friedrich Miescher Institute), Mohamed Bentires‐Alj(University of Basel)
Breast Cancer Research
April 5, 2016
Cited by 125


Related Papers